GDRX logo

GoodRx Holdings, Inc. (GDRX) Cash From Financing

Annual CFF:

-$337.50M-$170.10M(-101.62%)
December 31, 2024

Summary

  • As of today, GDRX annual cash from financing is -$337.50 million, with the most recent change of -$170.10 million (-101.62%) on December 31, 2024.
  • During the last 3 years, GDRX annual cash from financing has fallen by -$306.97 million (-1005.53%).
  • GDRX annual cash from financing is now -137.26% below its all-time high of $905.82 million, reached on December 31, 2020.

Performance

1-Year Change

-101.62%

3-Year Change

-1005.53%

5-Year Change

-516.08%

15-Year Change

-

GDRX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

6.71%
GDRX annual cash from financing is higher than 6.71% of companies in Healthcare sector

Range

All-Time High

$905.82M
GDRX annual cash from financing is currently -137.26% below its historical high of $905.82 million

3-Year Low

-$337.50M
GDRX annual cash from financing is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
GDRX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Feb 26, 2026
GDRX next annual earnings announcement is scheduled for Feb 26, 2026

OtherGDRXcash flow metrics

Annual CFI

-$70.35M
GDRX annual cash from investing is -$70.35 million

Annual CFO

$183.89M
GDRX annual cash from operations is $183.89 million

Annual FCF

$113.55M
GDRX annual free cash flow is $113.55 million

Annual CAPEX

$70.35M
GDRX annual capital expenditures is $70.35 million

Quarterly CFF:

-$65.81M-$14.88M(-29.23%)
September 30, 2025

Summary

  • As of today, GDRX quarterly cash from financing is -$65.81 million, with the most recent change of -$14.88 million (-29.23%) on September 30, 2025.
  • Over the past year, GDRX quarterly cash from financing has increased by +$106.32 million (+61.77%).
  • GDRX quarterly cash from financing is now -106.63% below its all-time high of $992.12 million, reached on September 30, 2020.

Performance

3-Month Change

-29.23%

1-Year Change

+61.77%

3-Year Change

-203.13%

5-Year Change

-106.63%

GDRX Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

7.67%
GDRX quarterly cash from financing is higher than 7.67% of companies in Healthcare sector

Range

All-Time High

$992.12M
GDRX quarterly cash from financing is currently -106.63% below its historical high of $992.12 million

3-Year Low

-$172.13M
GDRX quarterly cash from financing is currently +61.77% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
GDRX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 26, 2026
GDRX next earnings announcement is scheduled for Feb 26, 2026

OtherGDRXcash flow metrics

Quarterly CFI

-$18.00M
GDRX quarterly cash from investing is -$18.00 million

Quarterly CFO

$76.02M
GDRX quarterly cash from operations is $76.02 million

Quarterly FCF

$58.02M
GDRX quarterly free cash flow is $58.02 million

Quarterly CAPEX

$18.00M
GDRX quarterly capital expenditures is $18.00 million

TTM CFF:

-$225.17M+$106.32M(+32.07%)
September 30, 2025

Summary

  • As of today, GDRX TTM cash from financing is -$225.17 million, with the most recent change of +$106.32 million (+32.07%) on September 30, 2025.
  • Over the past year, GDRX TTM cash from financing has increased by +$234.40 million (+51.00%).
  • GDRX TTM cash from financing is now -122.14% below its all-time high of $1.02 billion, reached on September 30, 2020.

Performance

3-Month Change

+32.07%

1-Year Change

+51%

3-Year Change

-77.43%

5-Year Change

-122.14%

GDRX TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

9.39%
GDRX TTM cash from financing is higher than 9.39% of companies in Healthcare sector

Range

All-Time High

$1.02B
GDRX TTM cash from financing is currently -122.14% below its historical high of $1.02 billion

3-Year Low

-$459.57M
GDRX TTM cash from financing is currently +51.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
GDRX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 26, 2026
GDRX next earnings announcement is scheduled for Feb 26, 2026

OtherGDRXcash flow metrics

TTM CFI

-$104.83M
GDRX TTM cash from investing is -$104.83 million

TTM CFO

$179.76M
GDRX TTM cash from operations is $179.76 million

TTM FCF

$104.92M
GDRX TTM free cash flow is $104.92 million

TTM CAPEX

$74.83M
GDRX TTM capital expenditures is $74.83 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

GDRX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-101.6%+61.8%+51.0%
3Y3 Years-1005.5%-203.1%-77.4%
5Y5 Years-516.1%-106.6%-122.1%

GDRX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-1005.5%at low-7517.3%+61.8%-424.7%+51.0%
5Y5-Year-137.3%at low-106.6%+61.8%-122.1%+51.0%
All-TimeAll-Time-137.3%at low-106.6%+61.8%-122.1%+51.0%

GDRX Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$65.81M(-29.2%)
-$225.17M(+32.1%)
Jun 2025
-
-$50.93M(+51.5%)
-$331.49M(-17.8%)
Mar 2025
-
-$104.90M(-2871.7%)
-$281.43M(+16.6%)
Dec 2024
-$337.50M(-101.6%)
-$3.53M(+97.9%)
-$337.50M(+26.6%)
Sep 2024
-
-$172.13M(>-9900.0%)
-$459.57M(-52.6%)
Jun 2024
-
-$864.00K(+99.5%)
-$301.15M(+4.2%)
Mar 2024
-
-$160.97M(-28.2%)
-$314.28M(-87.7%)
Dec 2023
-$167.40M(-39.2%)
-$125.61M(-816.4%)
-$167.40M(-259.4%)
Sep 2023
-
-$13.71M(+2.1%)
-$46.58M(+14.7%)
Jun 2023
-
-$13.99M(+0.7%)
-$54.58M(-27.2%)
Mar 2023
-
-$14.09M(-194.4%)
-$42.91M(+64.3%)
Dec 2022
-$120.23M
-$4.79M(+78.0%)
-$120.23M(+5.3%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$21.71M(-832.6%)
-$126.91M(-16.0%)
Jun 2022
-
-$2.33M(+97.5%)
-$109.37M(-1.4%)
Mar 2022
-
-$91.40M(-697.2%)
-$107.91M(-253.5%)
Dec 2021
-$30.53M(-103.4%)
-$11.46M(-174.3%)
-$30.53M(+76.6%)
Sep 2021
-
-$4.18M(-383.2%)
-$130.44M(-115.1%)
Jun 2021
-
-$865.00K(+93.8%)
$865.87M(+0.2%)
Mar 2021
-
-$14.02M(+87.4%)
$864.20M(-4.6%)
Dec 2020
$905.82M(+1753.5%)
-$111.37M(-111.2%)
$905.82M(-10.9%)
Sep 2020
-
$992.12M(>+9900.0%)
$1.02B(+3957.6%)
Jun 2020
-
-$2.53M(-109.2%)
$25.07M(-9.2%)
Mar 2020
-
$27.60M
$27.60M
Dec 2019
-$54.78M(-121.5%)
-
-
Dec 2018
-$24.73M
-
-

FAQ

  • What is GoodRx Holdings, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for GoodRx Holdings, Inc.?
  • What is GoodRx Holdings, Inc. annual cash from financing year-on-year change?
  • What is GoodRx Holdings, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for GoodRx Holdings, Inc.?
  • What is GoodRx Holdings, Inc. quarterly cash from financing year-on-year change?
  • What is GoodRx Holdings, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for GoodRx Holdings, Inc.?
  • What is GoodRx Holdings, Inc. TTM cash from financing year-on-year change?

What is GoodRx Holdings, Inc. annual cash from financing?

The current annual cash from financing of GDRX is -$337.50M

What is the all-time high annual cash from financing for GoodRx Holdings, Inc.?

GoodRx Holdings, Inc. all-time high annual cash from financing is $905.82M

What is GoodRx Holdings, Inc. annual cash from financing year-on-year change?

Over the past year, GDRX annual cash from financing has changed by -$170.10M (-101.62%)

What is GoodRx Holdings, Inc. quarterly cash from financing?

The current quarterly cash from financing of GDRX is -$65.81M

What is the all-time high quarterly cash from financing for GoodRx Holdings, Inc.?

GoodRx Holdings, Inc. all-time high quarterly cash from financing is $992.12M

What is GoodRx Holdings, Inc. quarterly cash from financing year-on-year change?

Over the past year, GDRX quarterly cash from financing has changed by +$106.32M (+61.77%)

What is GoodRx Holdings, Inc. TTM cash from financing?

The current TTM cash from financing of GDRX is -$225.17M

What is the all-time high TTM cash from financing for GoodRx Holdings, Inc.?

GoodRx Holdings, Inc. all-time high TTM cash from financing is $1.02B

What is GoodRx Holdings, Inc. TTM cash from financing year-on-year change?

Over the past year, GDRX TTM cash from financing has changed by +$234.40M (+51.00%)
On this page